Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Artivion
AORT
$1.32B
| $9.31M | ﹤0.01% |
219,857
+59,140
| +37% | +$2.23M |
|
3027
Ocular Therapeutix
OCUL
$2.02B
| $9.3M | ﹤0.01% |
795,968
+190,803
| +32% | +$2.28M |
|
3028
Aurinia Pharmaceuticals
AUPH
$2.11B
| $9.3M | ﹤0.01% |
842,027
+403,007
| +92% | +$4.4M |
|
3029
CALL
CAVA Group
CAVA
$7.27B
| $9.29M | ﹤0.01% |
153,800
-266,400
| -63% | -$20.2M |
|
3030
PUT
Eaton
ETN
$174B
| $9.28M | ﹤0.01% |
24,800
+17,800
| +254% | +$6.47M |
|
3031
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
| $9.28M | ﹤0.01% |
74,182
+12,477
| +20% | +$1.47M |
|
3032
NB Bancorp
NBBK
$989M
| $9.26M | ﹤0.01% |
524,898
+50,142
| +11% | +$920K |
|
|
MTSR
3033
DELISTED
Metsera Inc
MTSR
| $9.25M | ﹤0.01% |
176,847
+137,897
| +354% | +$5.09M |
|
3034
Mativ Holdings
MATV
$711M
| $9.25M | ﹤0.01% |
817,419
+184,585
| +29% | +$1.83M |
|
3035
Quantum Computing Inc
QUBT
$2.07B
| $9.21M | ﹤0.01% |
500,340
-191,132
| -28% | -$3.28M |
|
3036
First Bancorp
FBNC
$2.68B
| $9.21M | ﹤0.01% |
174,112
+58,658
| +51% | +$3.01M |
|
3037
Tronox
TROX
$1.04B
| $9.21M | ﹤0.01% |
2,290,312
+560,479
| +32% | +$2.56M |
|
|
SFIX
3038
Stitch Fix
SFIX
$560M
| $9.2M | ﹤0.01% |
2,115,093
+282,836
| +15% | +$1.4M |
|
3039
Kulicke & Soffa
KLIC
$4.78B
| $9.17M | ﹤0.01% |
225,633
-17,490
| -7% | -$648K |
|
3040
CALL
Thermo Fisher Scientific
TMO
$220B
| $9.17M | ﹤0.01% |
18,900
+16,300
| +627% | +$7.59M |
|
3041
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $9.16M | ﹤0.01% |
91,400
+30,000
| +49% | +$2.7M |
|
3042
Petrobras Class A
PBR.A
$103B
| $9.15M | ﹤0.01% |
774,352
-5,515,178
| -88% | -$63.8M |
|
3043
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $9.15M | ﹤0.01% |
316,569
-995,567
| -76% | -$28.6M |
|
3044
Enact Holdings
ACT
$6.73B
| $9.13M | ﹤0.01% |
238,214
-464,247
| -66% | -$17.2M |
|
3045
Adeia
ADEA
$3.11B
| $9.12M | ﹤0.01% |
542,648
+69,842
| +15% | +$1.03M |
|
3046
Addus HomeCare
ADUS
$2.23B
| $9.09M | ﹤0.01% |
77,055
+33,079
| +75% | +$3.71M |
|
|
NSA
3047
DELISTED
National Storage Affiliates Trust
NSA
| $9.08M | ﹤0.01% |
300,443
+132,881
| +79% | +$4.15M |
|
3048
Scholastic
SCHL
$792M
| $9.08M | ﹤0.01% |
331,453
+95,843
| +41% | +$2.37M |
|
3049
PUT
First Solar
FSLR
$26.9B
| $9.06M | ﹤0.01% |
41,100
-104,900
| -72% | -$20.1M |
|
|
PHLT
3050
DELISTED
Performant Healthcare Inc
PHLT
| $9.05M | ﹤0.01% |
1,171,169
+1,097,227
| +1,484% | +$6.98M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.